The FDA said Pfizer's antibiotic Tygacil was associated with a higher death rate compared with other drugs when used to treat serious infections, and it suggested doctors limit use of the product.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304795804579101240693548748.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304795804579101240693548748.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento